BioSpace News Archive

Transthyretin amyloidosis is a rare progressive fatal disease that destroys the nerve cells controlling various bodily functions. The symptoms of the disease are similar to those of many other diseases.

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported that the parent company of its collaboration partner, NRx Pharmaceuticals, Inc., has issued a CEO Update announcing that the U.S. Food and Drug Administration has denied Breakthrough Therapy Designation for aviptadil.

Bushu Pharmaceuticals Ltd. has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its “Gateway to Asia” service to four countries across the Asia-Pacific region as Amgen’s contract manufacturing organization.

We have now several clinics activated in the phase III study CONCLUDE and look forward to enrol the first patient in the near term.

Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, announced the completion of $40M Series A financing.

Veracyte, Inc. announced that the Swedish Medical Technologies Product Council has recommended the Prosigna Breast Cancer Assay for immediate reimbursement and clinical use in all Swedish healthcare regions without legal restrictions beginning November 22, 2021.

ViewRay, Inc. today announced, in recognition of Pancreatic Cancer Awareness Month, more than 2,300 pancreatic cancer patients have been treated with MRIdian at 46 centers around the world.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that management will present at the virtual 45th Nasdaq Investor Conference on Friday, December 3, 2021 at 11:30 a.m..

Merck to Present at the 4th Annual Evercore ISI HealthCONx Conference.

Ginkgo Bioworks announced today that management is scheduled to participate in the following upcoming conferences.